a16z Podcast: What Technology Wants, Needs, Does
The a16z Show23 Touko 2017

a16z Podcast: What Technology Wants, Needs, Does

Turnabout is fair play: That's true in politics, and it's true at Andreessen Horowitz given our internal (and very opinionated!) culture of debate -- where we often agree to disagree, or more often, disagree to agree. So in this special "turnabout" episode of the a16z Podcast, co-founder Marc Andreessen (who is most often in the hot seat being interviewed), got the chance to instead grill fellow partners Frank Chen (who covers AI and much more), Vijay Pande (who covers healthcare for the bio fund), and Alex Rampell (who covers all things fintech).

None of the partners had any idea what Marc would ask them. Putting them in the hot seat at our recent a16z Tech Policy Summit, in Washington, D.C., Marc asked them policy questions such as the implications for tech of the American Health Care Act or AHCA (which itself was being hotly debated that exact same day, just a few miles away); the role of regulatory arbitrage; and what happens to companies big and small if Dodd-Frank is repealed.

Oh, but they also covered so much more: the pros and cons of using tech to "discriminate" for better risk pooling; the role of genetics in addiction (can/should it be used to determine risk?); the opioid crisis (can tech help?); applying AI as a "salve" for everything (what's hyped, what's real, what's easy, what's hard?); the line between redlining and predatory lending (and where/when did sentiment flip?); and the ethics of artificial intelligence (beyond the ole Trolley Problem). Throw in a classic nature vs. nurture debate, a bit of 2-D vs. 3-D, and some fries (yes)... and the future arrives in this episode in 35 minutes or less.

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaksot(1000)

Online Learning and the Ed Tech Debate

Online Learning and the Ed Tech Debate

This episode is all about education and technology, a topic that’s especially top of mind this week as students in much of the country return to school—virtually. The intersection of learning and tech...

17 Elo 202048min

On Vaccines and Vaccinology, in COVID and Beyond

On Vaccines and Vaccinology, in COVID and Beyond

WHEN are we going to have a COVID-19 vaccine, and how the heck are we going from (what’s been traditionally been up to) 12 years or so of vaccine development compressed into 12 months or so? What will...

14 Elo 202056min

Turning Open Source Developers Into Superfans

Turning Open Source Developers Into Superfans

In this episode, we continue our community series with a recent discussion that applies to many kinds of community building. Today’s topic: How do you create a platform that people not only use, but t...

10 Elo 202045min

Journal Club: Slaying the Sleeper Cells of Aging with CAR T

Journal Club: Slaying the Sleeper Cells of Aging with CAR T

CAR T therapy is a groundbreaking medicine that uses engineered T cells to attack cancer. But CAR T cells (that is, chimeric antigen receptor T cells) can be programmed to recognize a huge range of ta...

9 Elo 202018min

Working, Making, Creating in Public... and Private

Working, Making, Creating in Public... and Private

We're living in an unprecedented era of online collaboration, coordination, and creation. All kinds of people are coming together -- whether in an open source project or company, an R&D initiative, a ...

2 Elo 202047min

GPT-3: What's Hype, What's Real on the Latest in AI

GPT-3: What's Hype, What's Real on the Latest in AI

In this episode -- cross posted from our 16 Minutes show feed -- we cover all the buzz around GPT-3, the pre-trained machine learning model from OpenAI that’s optimized to do a variety of natural-lang...

30 Heinä 202033min

Taking the Pulse on Medical Device Security

Taking the Pulse on Medical Device Security

Many don’t realize we even need to think about the possibility of security hacks when it comes to things like pacemakers, insulin pumps, and more. But when bits and bytes meet flesh and blood, securit...

22 Heinä 202023min

Journal Club: A New Path to Antibiotic Resistance

Journal Club: A New Path to Antibiotic Resistance

Ever since the discovery of antibiotics, microbiologists have worried about and studied how bacteria acquire resistance to these drugs. Adding to the complexity of this problem is the fact that it is ...

19 Heinä 202017min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
rss-rahapodi
psykopodiaa-podcast
mimmit-sijoittaa
rss-oivalluksia-rahasta-elamasta
hyva-paha-johtaminen
rss-rahamania
rss-paasipodi
ostan-asuntoja-podcast
rahapuhetta
rss-sisalto-kuntoon
herrasmieshakkerit
leadcast
lakicast
rss-lahtijat
rss-startup-ministerio
rss-kaikki-somesta
rss-karon-grilli
rss-inderes
rss-set-for-life-sijoita-ja-vaurastu